Clinical Trial Update: Neoadjuvant Triple Therapy for Resectable HCC

View source ↗

Summary

A clinical trial update on neoadjuvant triple therapy for resectable hepatocellular carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fujian Provincial Hospital | Conditions: Resectable Hepatocellular Carcinoma | Status: RECRUITING